Crane Co Income Taxes Disclosure
| (in millions) For year ended December 31, | 2025 | 2024 | 2023 | |||||||||||||||||
| U.S. operations | $ | 312.8 | $ | 207.0 | $ | 127.1 | ||||||||||||||
| Non-U.S. operations | 120.0 | 131.5 | 106.0 | |||||||||||||||||
| Total | $ | 432.8 | $ | 338.5 | $ | 233.1 | ||||||||||||||
| (in millions) For the year ended December 31, | 2025 | 2024 | 2023 | |||||||||||||||||
| Current: | ||||||||||||||||||||
| U.S. federal tax | $ | 58.7 | $ | 39.7 | $ | 36.0 | ||||||||||||||
| U.S. state and local tax | 6.7 | 4.0 | 3.8 | |||||||||||||||||
| Non-U.S. tax | 37.8 | 38.2 | 36.1 | |||||||||||||||||
| Total current | 103.2 | 81.9 | 75.9 | |||||||||||||||||
| Deferred: | ||||||||||||||||||||
| U.S. federal tax | 1.2 | (7.4) | (13.0) | |||||||||||||||||
| U.S. state and local tax | 0.1 | (1.7) | (1.5) | |||||||||||||||||
| Non-U.S. tax | (3.4) | (2.5) | (4.2) | |||||||||||||||||
| Total deferred | (2.1) | (11.6) | (18.7) | |||||||||||||||||
| Total provision for income taxes | $ | 101.1 | $ | 70.3 | $ | 57.2 | ||||||||||||||
| (in millions, except %) For the year ended December 31, 2025 | Amount | Percent | ||||||||||||
| US Federal Statutory Tax Rate | $ | 90.9 | 21.0 | % | ||||||||||
| State and Local Income Taxes, Net of Federal Income Tax Effect* | 5.1 | 1.2 | % | |||||||||||
| Foreign Tax Effects | ||||||||||||||
| Other Foreign jurisdictions | 9.3 | 2.1 | % | |||||||||||
| Effect of Cross-Boarder Tax Laws | ||||||||||||||
| Global intangible low-taxed income | 11.0 | 2.5 | % | |||||||||||
| Foreign-derived intangible income | (7.2) | (1.7) | % | |||||||||||
| Other | 2.2 | 0.5 | % | |||||||||||
| Tax Credits | ||||||||||||||
| Research and development tax credits | (3.0) | (0.7) | % | |||||||||||
| Foreign tax credits | (11.9) | (2.7) | % | |||||||||||
| Changes in valuation allowances | (0.1) | — | % | |||||||||||
| Nontaxable or Nondeductible Items | ||||||||||||||
| Equity Compensation | (9.8) | (2.3) | % | |||||||||||
| Non-Deductible Officers Compensation | 9.4 | 2.2 | % | |||||||||||
| Other | 3.4 | 0.8 | % | |||||||||||
| Changes in unrecognized tax benefits | 2.1 | 0.5 | % | |||||||||||
| Other Adjustments | (0.3) | — | % | |||||||||||
| Effective Tax Rate | $ | 101.1 | 23.4 | % | ||||||||||
| For the year ended December 31, | 2024 | 2023 | |||||||||||||||
| Statutory U.S. federal tax rate | 21.0 | % | 21.0 | % | |||||||||||||
| Increase (reduction) from: | |||||||||||||||||
| Income taxed at non-U.S. rates | 2.4 | % | 4.1 | % | |||||||||||||
| Non-U.S. income inclusion, net of tax credits | 0.4 | % | (1.7) | % | |||||||||||||
| State and local taxes, net of federal benefit | 0.5 | % | 0.7 | % | |||||||||||||
| U.S. research and development tax credit | (1.3) | % | (0.8) | % | |||||||||||||
| U.S. deduction for foreign - derived intangible income | (1.5) | % | (1.9) | % | |||||||||||||
| Non-deductible expenses | 2.5 | % | 4.4 | % | |||||||||||||
| Equity Compensation | (2.6) | % | (2.1) | % | |||||||||||||
| Other | (0.7) | % | 0.8 | % | |||||||||||||
| Effective tax rate | 20.8 | % | 24.5 | % | |||||||||||||
| (in millions) For year ended December 31, | 2025 | |||||||
| Federal | $ | 53.8 | ||||||
| State | 5.3 | |||||||
| Foreign: | ||||||||
| France | 5.8 | |||||||
| United Kingdom | 7.6 | |||||||
| Other foreign jurisdictions | 24.0 | |||||||
| Total | $ | 96.5 | ||||||
| (in millions) | Permanently reinvested | Not permanently reinvested | ||||||||||||
| Amount of earnings | $ | 232.9 | $ | 803.7 | ||||||||||
| Associated tax | NA * | $ | 10.3 | |||||||||||
* Determination of U.S. income taxes and non-U.S. withholding taxes due upon repatriation of this $232.9 million of earnings is not practicable because the amount of such taxes depends upon circumstances existing in numerous taxing jurisdictions at the time the remittance occurs. | ||
| (in millions) December 31, | 2025 | 2024 | ||||||||||||
| Deferred tax assets: | ||||||||||||||
| Tax loss and credit carryforwards | $ | 40.5 | $ | 45.5 | ||||||||||
| Inventories | 33.1 | 30.0 | ||||||||||||
| Deferred tax asset related to the sale of a subsidiary | — | 7.2 | ||||||||||||
| Capitalized research and development | 20.6 | 28.1 | ||||||||||||
| Stock Based Compensation | 6.0 | 5.8 | ||||||||||||
| Other | 13.9 | 13.8 | ||||||||||||
| Total | $ | 114.1 | $ | 130.4 | ||||||||||
| Less: valuation allowance | 40.9 | 46.2 | ||||||||||||
| Total deferred tax assets, net of valuation allowance | $ | 73.2 | $ | 84.2 | ||||||||||
| Deferred tax liabilities: | ||||||||||||||
| Basis difference in fixed assets | $ | (28.4) | $ | (28.2) | ||||||||||
| Basis difference in intangible assets | (65.0) | (67.4) | ||||||||||||
| Pension and post-retirement benefits | (11.9) | (2.0) | ||||||||||||
| Deferred tax on non-U.S. unremitted earnings | (10.3) | (10.2) | ||||||||||||
| Total deferred tax liabilities | $ | (115.6) | $ | (107.8) | ||||||||||
| Net deferred tax asset (liability) | $ | (42.4) | $ | (23.6) | ||||||||||
| Balance sheet classification: | ||||||||||||||
| Long-term deferred tax assets | 3.5 | 11.2 | ||||||||||||
| Long-term deferred tax liability | (45.9) | (34.8) | ||||||||||||
| Net deferred tax asset (liability) | $ | (42.4) | $ | (23.6) | ||||||||||
| (in millions) Year of expiration | U.S. Federal Tax Credits | U.S. State Tax Credits | U.S. State Tax Effected Losses | Non- U.S. Tax Effected Losses | Total | ||||||||||||||||||||||||||||||
| 2026-2030 | $ | — | $ | 0.4 | $ | 1.1 | $ | 0.8 | $ | 2.3 | |||||||||||||||||||||||||
| After 2030 | 1.3 | 0.3 | 5.6 | 0.2 | 7.4 | ||||||||||||||||||||||||||||||
| Indefinite | — | 15.7 | 2.5 | 12.6 | 30.8 | ||||||||||||||||||||||||||||||
| Deferred tax asset on tax carryforwards | $ | 1.3 | $ | 16.4 | $ | 9.2 | $ | 13.6 | $ | 40.5 | |||||||||||||||||||||||||
| (in millions) | 2025 | 2024 | 2023 | |||||||||||||||||
| Balance of liability as of January 1, | $ | 8.4 | $ | 7.9 | $ | 6.9 | ||||||||||||||
| Increase as a result of tax positions taken during a prior year | 0.2 | 0.1 | 0.2 | |||||||||||||||||
| Decrease as a result of tax positions taken during a prior year | — | (0.4) | (0.1) | |||||||||||||||||
| Increase as a result of tax positions taken during the current year | 2.1 | 1.9 | 1.7 | |||||||||||||||||
| Decrease as a result of settlements with taxing authorities | — | — | — | |||||||||||||||||
| Reduction as a result of a lapse of the statute of limitations | (0.4) | (1.1) | (0.8) | |||||||||||||||||
| Balance of liability as of December 31, | $ | 10.3 | $ | 8.4 | $ | 7.9 | ||||||||||||||
| Jurisdiction | Year | |||||||
| U.S. state and local | 2019 - 2024 | |||||||
| Non-U.S. | 2019 - 2024 | |||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Feb 27, 2025 | |
| 2023 | Feb 26, 2024 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.